Amedica has implanted 10,000 Valeo Interbody Fusion Devices in patients

IT’S 10,000 AND COUNTING AT AMEDICA (Orthopedics This Week) Amedica Corporation has now implanted 10,000 of its Valeo Interbody Fusion Devices in patients located in ten countries worldwide, according to a company press release. The Valeo Interbody Fusion Device System is made of Amedica’s proprietary Silicon Nitride ceramic technology and is used during surgical procedures to treat spinal disorders such as spondylolisthesis, scoliosis, severe disc degeneration, or spinal fractures. Company officials say that because of the device’s record of promoting superior new bone growth and its antibacterial properties, surgeons at leading hospitals worldwide are increasingly relying on it to increase the probability of fusion in their patients. The first time a surgeon used the company’s proprietary silicon nitride implant was in May of 2008, according to a company spokesperson. “In my four years of experience with Silicon Nitride Interbody Fusion Devices, I’ve seen the material exceed the capabilities of poly-ether-ether-ketone (PEEK) or titanium (Ti), resulting in better fusion, which translates to better results for my patients,” said Grant Skidmore, M.D., of Neurosurgical Specialists, I...


Unlock the full article and exclusive OrthoStreams insights: in-depth analyses, hot startups, trends, market intel, and Daily Newsletter—for just $1/day.
Subscribe Now—Up your Game !
 

Scroll to Top